Pharmaceuticals distributor Ebos says its application to list on the Australian Stock Exchange has been approved.
The company's shares will start trading in Australian from about 6 December.
Managing director Mark Waller says the dual listing will facilitate the ability for Australian institutions and retail investors to trade in Ebos shares which should make trading easier for all shareholders.
Mr Waller says his company has received increasing interest from Australian investors since it bought the Australia-based Symbion for $1.1 billion earlier this year.
